Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BenQ Medical TechnologyROCO:4116 +0.39%81 Days Payable is 58.18 as of Dec. 2025, which is 7% below its 10-year median of 62.51. GuruFocus rates ROCO:4116 with a GF Score™ of 81/100 and a GF Value™ of NT$62.38 (Significantly Undervalued). The stock has 6 warning signs investors should review. Among 795 Medical Devices & Instruments companies, BenQ Medical Technology ranks worse than 57.23% on this metric.
The historical rank and industry rank for BenQ Medical Technology's Days Payable or its related term are showing as below:
ROCO:4116'
s Days Payable Range Over the Past 10 Years
Min: 41.07 Med: 62.51 Max: 78.01
Current: 60.94
During the past 13 years, BenQ Medical Technology's highest Days Payable was 78.01. The lowest was 41.07. And the median was 62.51.
ROCO:4116's Days Payable is ranked worse than 57.23% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 67.87
vs ROCO:4116: 60.94
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:4116 vs ISRG, BDX, MDLN: Days Payable Comparison
For the Medical Instruments & Supplies subindustry, BenQ Medical Technology's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BenQ Medical Technology Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, BenQ Medical Technology's Days Payable distribution charts can be found below:
* The bar in red indicates where BenQ Medical Technology's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
BenQ Medical Technology's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BenQ Medical Technology (ROCO:4116) has a Days Payable of 58.18 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on BenQ Medical Technology and its competitors. This is near median its historical median of 62.51. Over the past decade, BenQ Medical Technology's Days Payable has ranged from 41.07 to 78.01. According to the industry distribution chart, BenQ Medical Technology ranks #455 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 57.2%.
Is BenQ Medical Technology's Days Payable too high?
BenQ Medical Technology's current Days Payable of 58.18 is near median its 10-year median of 62.51. Over the past 10 years, this metric has ranged from a low of 41.07 to a high of 78.01. The Medical Devices & Instruments industry median Days Payable is 67.87. BenQ Medical Technology's value of 58.18 is 14.3% below this industry median. Based on the distribution chart, BenQ Medical Technology ranks #455 out of 795 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, BenQ Medical Technology has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does BenQ Medical Technology's Days Payable compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, BenQ Medical Technology ranks #455 out of 795 companies for Days Payable. This places BenQ Medical Technology in the lower half of its industry. The industry median Days Payable is 67.87. BenQ Medical Technology's value of 58.18 is 14.3% below this benchmark. Historically, BenQ Medical Technology's own Days Payable has ranged from 41.07 to 78.01 over the past decade. While the company's 10-year median is 62.51 vs. the industry median of 67.87, BenQ Medical Technology has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.87, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BenQ Medical Technology's current Days Payable of 58.18 is 14.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on BenQ Medical Technology and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BenQ Medical Technology's current Days Payable is 58.18, which is near median its own 10-year median of 62.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BenQ Medical Technology stock overvalued right now?
Based on GuruFocus' analysis, BenQ Medical Technology (ROCO:4116) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$62.38, compared to a current price of NT$38.60 — trading 38.1% below its estimated fair value. The current Days Payable is 58.18, which is near median its 10-year median of 62.51 and 14.3% below the Medical Devices & Instruments industry median of 67.87. BenQ Medical Technology's overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For BenQ Medical Technology (ROCO:4116), the current Days Payable is 58.18 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BenQ Medical Technology (ROCO:4116) Overvalued in 2026?
Based on GuruFocus' analysis, BenQ Medical Technology stock appears to be undervalued.
The current stock price of NT$38.60 is trading 38.1% below its estimated GF Value™ of NT$62.38.
GuruFocus considers BenQ Medical Technology to be Significantly Undervalued.
Key valuation signals for ROCO:4116:
Days Payable: 58.18 (near median its 10-year median of 62.51)
GF Value™: NT$62.38 vs. price of NT$38.60 (38.1% below fair value)
Industry Position: 14.3% below the Medical Devices & Instruments median (#455 of 795)
No single metric tells the full story. See the ROCO:4116 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BenQ Medical Technology Corp is engaged in the manufacturing, assembly, maintenance, repair, and sales of professional medical equipment and consumables. Its products include surgical and gynecology tables, digital OR solutions, halogen and LED surgical lights, and medical imaging products, among others. The company's segment includes the R&D and Manufacturing Division and the Medical Services Division. The company generates the majority of its revenue from the Medical Services Division. Geographically, the company generates revenue from Taiwan, Mainland China, Indonesia, Thai, India, Colombia, and Others.
81GF Score
Get the complete analysis for ROCO:4116
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4116 has been successfully added to your 
